https://www.europesays.com/us/1393/ JNJ’s Consistent Payout Makes It a Top Pick for Down Markets #BabyCareProducts #BestDividendStocks #Business #Johnson&Johnson #Markets #NYSE:JNJ #SmilingBaby #UnitedStates #UnitedStates #US
https://www.europesays.com/us/1393/ JNJ’s Consistent Payout Makes It a Top Pick for Down Markets #BabyCareProducts #BestDividendStocks #Business #Johnson&Johnson #Markets #NYSE:JNJ #SmilingBaby #UnitedStates #UnitedStates #US
The $5M Insider Vote of Confidence in United Health
UnitedHealth Group (NYSE: UNH) recently crashed after the U.S. Department of Justice might start a criminal investigation into…
#Economy #business #Companies #grossprofitmargin #NYSE #PeerGroup #RevenueGrowth #ROE #U.S.DepartmentofJustice
https://www.europesays.com/2179551/
Voyager Technologies, a US aerospace and defense firm, raised $382.8 million in its NYSE IPO, pricing above expectations amid renewed military spending under the Trump administration.
#YonhapInfomax #VoyagerTechnologies #IPO #NYSE #MilitarySpending #TrumpAdministration #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=67006
St. Louis Blues Partner with Gray Media to Broadcast Three https://www.rawchili.com/nhl/65068/ #Blues #GrayMedia #Hockey #NHL #NYSE:GTN #St.Louis #St.LouisBlues #StLouis #StLouisBlues
https://www.alojapan.com/1291912/japan-smaller-capitalization-fund-inc-announces/ Japan Smaller Capitalization Fund, Inc. Announces ##CEF #Japan #JapanNews #JapanSmallerCapitalizationFund #JOF #news #NYSE:JOF NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) — Japan Smaller Capitalization Fund, Inc. (the “Fund”) (NYSE: JOF) today announced that its Board of Directors (the “Board”) has approved two initiatives aimed at addressing the Fund’s trading discount. These initiatives include a level distribution plan and a conditional tende…
Circle stock tripled after IPO debut! 📈
The company behind USDC stablecoin launched on the NYSE at $31 - but surged past $100 in the first hour! Multiple trading halts followed due to extreme volatility. We summarize everything about the launch here: https://auriccrypto.com/stable/circle-stock-triples-after-public-debut-on-nyse/
Novartis' Pluvicto shows promise in earlier-stage prostate cancer - published 02 Jun 2025 #today #NYSE #ClinicalTrials #Tech #Technology
https://grafa.com/news/health-novartis--pluvicto-shows-promise-in-earlier-stage-prostate-cancer-442739?utm_source=us_news_en&utm_medium=mastodon&utm_campaign=442739
Pfizer and Arvinas announce positive phase 3 trial results for vepdegestran... - published 02 Jun 2025 #today #NYSE #ClinicalTrials #media #Nasdaq
https://grafa.com/news/health-pfizer-and-arvinas-announce-positive-phase-3-trial-results-for-vepdegestrant-in-advanced-breast-cancer-442785?utm_source=us_news_en&utm_medium=mastodon&utm_campaign=442785
Theravance Biopharma sells remaining royalty interest in Trelegy Ellipta to... - published 02 Jun 2025 #today #NYSE #Strategic #DeFi #Nasdaq
https://grafa.com/news/health-theravance-biopharma-sells-remaining-royalty-interest-in-trelegy-ellipta-to-gsk-for--225m-442768?utm_source=us_news_en&utm_medium=mastodon&utm_campaign=442768
Protagonist Therapeutics and Takeda announce breakthrough results for rusfe... - published 02 Jun 2025 #today #NYSE #management #Nasdaq #SEC
https://grafa.com/news/health-protagonist-therapeutics-and-takeda-announce-breakthrough-results-for-rusfertide-in-polycythemia-vera-442767?utm_source=us_news_en&utm_medium=mastodon&utm_campaign=442767
GSK's linerixibat NDA accepted by FDA for review in cholestatic pruritus as... - published 02 Jun 2025 #today #NYSE #live #Food #SEC
https://grafa.com/news/health-gsk-s-linerixibat-nda-accepted-by-fda-for-review-in-cholestatic-pruritus-associated-with-pbc-442815?utm_source=us_news_en&utm_medium=mastodon&utm_campaign=442815
BioNTech and Bristol Myers Squibb forge landmark collaboration for bispecif... - published 02 Jun 2025 #today #NYSE #Tech #Nasdaq #Payments
https://grafa.com/news/health-biontech-and-bristol-myers-squibb-forge-landmark-collaboration-for-bispecific-antibody-bnt327-in-solid-tumors-442827?utm_source=us_news_en&utm_medium=mastodon&utm_campaign=442827
UPS appoints former Sherwin-Williams CEO John Morikis to board - published 02 Jun 2025 #today #NYSE #media #management #Innovation
https://grafa.com/news/transport-and-logistics-ups-appoints-former-sherwin-williams-ceo-john-morikis-to-board-442831?utm_source=us_news_en&utm_medium=mastodon&utm_campaign=442831
Major ad firms stock drop following report that Meta plans to fully automat... - published 02 Jun 2025 #today #NYSE #trading #media #WallStreet
https://grafa.com/news/technology-major-ad-firms-stock-drop-following-report-that-meta-plans-to-fully-automate-ad-creation-with-ai-442851?utm_source=us_news_en&utm_medium=mastodon&utm_campaign=442851
Toyota Industries poised to accept $42B takeover bid from Toyota Motor - published 02 Jun 2025 #today #NYSE #trading #News #SupplyChain
https://grafa.com/news/auto-and-cars-toyota-industries-poised-to-accept--42b-takeover-bid-from-toyota-motor-442916?utm_source=us_news_en&utm_medium=mastodon&utm_campaign=442916
U.S. demands divestitures for Keysight-Spirent merger approval, citing anti... - published 02 Jun 2025 #government #NYSE #media #Tech #Court
https://grafa.com/news/technology-u-s--demands-divestitures-for-keysight-spirent-merger-approval--citing-antitrust-concerns-442948?utm_source=us_news_en&utm_medium=mastodon&utm_campaign=442948
AXEL REE LIMITED ( #AXL ) has released " Axel Undertakes Strategic Leadership Transition " on Fri 30 May at 09:20 AEST #Commodity #NYSE #Mining #Gold #Australia
https://grafa.com/asset/axel-ree-limited-30714-axl.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=axl.asx